# Chong‐Jen Yu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chong-jen-yu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,776 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 90 |
| i10-index | 506 |
| Last Known Institution | National Taiwan University Hospital |
| OpenAlex ID | https://openalex.org/A5013389671 |
| ORCID iD | 0000-0001-5664-9392 |
| Works | 959 |

## Researcher papers

Showing 12 of 23.

- [Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/osimertinib-in-resected-i-egfr-i-mutated-non-small-cell-lung-cancer/)
- [<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib](https://scholariq.org/papers/i-met-i-amplification-occurs-with-or-without-i-t790m-i-mutations-in-i-egfr-i/)
- [First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study](https://scholariq.org/papers/first-line-ceritinib-versus-platinum-based-chemotherapy-in-advanced-alk/)
- [Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6](https://scholariq.org/papers/clinical-activity-of-afatinib-in-patients-with-advanced-non-small-cell-lung/)
- [Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia](https://scholariq.org/papers/renal-involvement-and-early-prognosis-in-patients-with-covid-19-pneumonia/)
- [MicroRNA Signature Predicts Survival and Relapse in Lung Cancer](https://scholariq.org/papers/microrna-signature-predicts-survival-and-relapse-in-lung-cancer/)
- [Value of sonography in determining the nature of pleural effusion: analysis of 320 cases.](https://scholariq.org/papers/value-of-sonography-in-determining-the-nature-of-pleural-effusion-analysis-of/)
- [<i>Mycobacterium abscessus</i>Complex Infections in Humans](https://scholariq.org/papers/i-mycobacterium-abscessus-i-complex-infections-in-humans/)
- [Detection and Dynamic Changes of <i>EGFR</i> Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy](https://scholariq.org/papers/detection-and-dynamic-changes-of-i-egfr-i-mutations-from-circulating-tumor-dna/)
- [Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung Cancer](https://scholariq.org/papers/effectiveness-of-tyrosine-kinase-inhibitors-on-uncommon-epidermal-growth-factor/)
- [Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial](https://scholariq.org/papers/afatinib-for-patients-with-lung-adenocarcinoma-and-epidermal-growth-factor/)
- [Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial](https://scholariq.org/papers/adjuvant-osimertinib-for-resected-egfr-mutated-stage-ib-iiia-non-small-cell-lung/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Mycobacterium research and diagnosis](https://scholariq.org/topics/mycobacterium-research-and-diagnosis/)

## Researcher university

- [National Taiwan University Hospital](https://scholariq.org/institutions/national-taiwan-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.